{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:34:46Z","timestamp":1793316886727,"version":"4.5.0"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.semarthrit.2024.152467","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T15:16:23Z","timestamp":1716218183000},"page":"152467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The autoimmune landscape of Porto-sinusoidal vascular disorder: What the rheumatologist needs to know"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9534-6853","authenticated-orcid":false,"given":"Antonio","family":"Tonutti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ceribelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Isailovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Colapietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"De Nicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Polverini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0323-0376","authenticated-orcid":false,"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Aghemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10308","key":"10.1016\/j.semarthrit.2024.152467_bib0001","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152467_bib0002","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.mayocp.2018.12.020","article-title":"Portal Hypertension and related complications: diagnosis and management","volume":"94","author":"Simonetto","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152467_bib0003","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(19)30047-0","article-title":"Porto-sinusoidal vascular disease: proposal and description of a novel entity","volume":"4","author":"De Gottardi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152467_bib0004","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jhep.2022.05.033","article-title":"Porto-sinusoidal vascular disorder","volume":"77","author":"De Gottardi","year":"2022","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2024.152467_bib0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11894-020-00792-0","article-title":"Causes and Management of Non-cirrhotic Portal Hypertension","volume":"22","author":"Gioia","year":"2020","journal-title":"Curr Gastroenterol Rep"},{"issue":"1S Suppl 1","key":"10.1016\/j.semarthrit.2024.152467_bib0006","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/MEG.0000000000001980","article-title":"The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients","volume":"33","author":"Gilissen","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2024.152467_bib0007","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ejso.2013.09.015","article-title":"Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases","volume":"40","author":"Morris-Stiff","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152467_bib0008","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajh.20024","article-title":"Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders","volume":"75","author":"Al-Mukhaizeem","year":"2004","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0009","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0973-6883(12)60107-8","article-title":"Portal hypertension and ascites in extramedullary hematopoiesis","volume":"2","author":"Amarapurkar","year":"2012","journal-title":"J Clin Exp Hepatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152467_bib0010","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/hep.30578","article-title":"The Spectrum of Hepatic Involvement in Patients With Telomere Disease","volume":"69","author":"Kapuria","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.semarthrit.2024.152467_bib0011","article-title":"Liver disease in germline mutations of telomere-related genes: prevalence, clinical, radiological, pathological features, outcome, and risk factors","author":"Sidali","year":"2023","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152467_bib0012","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jhep.2021.05.014","article-title":"Co-expression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease","volume":"75","author":"Hern\u00e1ndez-Gea","year":"2021","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152467_bib0013","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1002\/hep.26904","article-title":"Idiopathic portal hypertension: natural history and long-term outcome","volume":"59","author":"Siramolpiwat","year":"2014","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.semarthrit.2024.152467_bib0014","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.dld.2018.01.132","article-title":"Natural history of patients with non cirrhotic portal hypertension: comparison with patients with compensated cirrhosis","volume":"50","author":"Gioia","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2024.152467_bib0015","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/liv.15257","article-title":"High prevalence of porto-sinusoidal vascular disease in patients with constantly elevated gamma-glutamyl transferase levels","volume":"42","author":"Pugliese","year":"2022","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152467_bib0016","article-title":"Porto-sinusoidal vascular disorder in chronic HBV: a significant coexistence not to be overlooked","volume":"6","author":"Olivas","year":"2024","journal-title":"JHEP Rep"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152467_bib0017","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.semarthrit.2024.152467_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/jcp-2023-209321","article-title":"Dissociation in hepatic vein pressure gradient, liver stiffness measurement and complications in histological subtypes of porto-sinusoidal vascular disease","author":"Bihari","year":"2024","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0019","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/j.cgh.2020.11.039","article-title":"Clinical course of porto-sinusoidal vascular disease is distinct from idiopathic noncirrhotic portal hypertension","volume":"20","author":"W\u00f6ran","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2013.08.013","article-title":"Non-cirrhotic portal hypertension - diagnosis and management","volume":"60","author":"Khanna","year":"2014","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152467_bib0021","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/2050640616680550","article-title":"Nodular regenerative hyperplasia rarely leads to liver transplantation: a 20-year cohort study in all Dutch liver transplant units","volume":"5","author":"Meijer","year":"2017","journal-title":"United Eur Gastroenterol J"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152467_bib0022","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/TP.0000000000004444","article-title":"Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: long-term Outcome","volume":"107","author":"Magaz","year":"2023","journal-title":"Transplantation."},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152467_bib0023","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.amjms.2016.10.014","article-title":"Lupus Hepatitis and Autoimmune Hepatitis (Lupoid Hepatitis)","volume":"353","author":"Adiga","year":"2017","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0024","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/2397198318802763","article-title":"Systemic sclerosis and primary biliary cholangitis: an overlapping entity?","volume":"4","author":"Lepri","year":"2019","journal-title":"J Scleroderma Relat Disord"},{"issue":"10139","key":"10.1016\/j.semarthrit.2024.152467_bib0025","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2024.152467_bib0026","article-title":"Exploring the link: porto-sinusoidal vascular disorder and inflammatory bowel disease - A comprehensive narrative review","author":"Pugliese","year":"2023","journal-title":"Dig Liver Dis."},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152467_bib0027","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bpg.2013.06.016","article-title":"Liver abnormalities in connective tissue diseases","volume":"27","author":"De Santis","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152467_bib0028","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules","volume":"11","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152467_bib0029","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1034\/j.1600-0676.2000.020005366.x","article-title":"The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver","volume":"20","author":"Matsumoto","year":"2000","journal-title":"Liver"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/0377-4929.77319","article-title":"Liver pathology in collagen vascular disorders highlighting the vascular changes within portal tracts","volume":"54","author":"Vaiphei","year":"2011","journal-title":"Indian J Pathol Microbiol"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152467_bib0031","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0046-8177(92)90033-Y","article-title":"The liver in systemic lupus erythematosus: pathologic analysis of 52 cases and review of Japanese Autopsy Registry Data","volume":"23","author":"Matsumoto","year":"1992","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0032","first-page":"e35494","article-title":"Non-Cirrhotic Portal Hypertension in Systemic Lupus Erythematosus","volume":"15","author":"Su\u00e1rez-D\u00edaz","year":"2023","journal-title":"Cureus."},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0033","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/24725625.2021.1904607","article-title":"A case of systemic lupus erythematosus with marked ascites due to idiopathic non-cirrhotic portal hypertension","volume":"5","author":"Imabayashi","year":"2021","journal-title":"Mod Rheumatol Case Rep"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0034","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2177\/jsci.27.40","article-title":"[Beneficial effect of glucocorticosteroids for esophageal varices due to idiopathic portal hypertension following systemic lupus erythematosus]","volume":"27","author":"Yamamoto","year":"2004","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152467_bib0035","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1177\/0961203306070976","article-title":"Association of nodular regenerative hyperplasia of the liver with porto-pulmonary hypertension in a patient with systemic lupus erythematosus","volume":"15","author":"Park","year":"2006","journal-title":"Lupus"},{"issue":"819","key":"10.1016\/j.semarthrit.2024.152467_bib0036","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/pgmj.70.819.41","article-title":"Pulmonary hypertension associated with non-cirrhotic portal hypertension in systemic lupus erythematosus","volume":"70","author":"Woolf","year":"1994","journal-title":"Postgrad Med J"},{"issue":"12","key":"10.1016\/j.semarthrit.2024.152467_bib0037","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1191\/0961203305lu2237xx","article-title":"Slow development of massive splenomegaly, portal and pulmonary hypertension in systematic lupus erythematosus: can nodular regenerative hyperplasia of the liver explain all these findings?","volume":"14","author":"Colmegna","year":"2005","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0038","first-page":"139","article-title":"Nodular regenerative hyperplasia of the liver associated with systemic lupus erythematosus: three cases","volume":"15","author":"Leung","year":"2009","journal-title":"Hong Kong Med J"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152467_bib0039","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s005350050336","article-title":"Idiopathic portal hypertension associated with systemic lupus erythematosus","volume":"35","author":"Inagaki","year":"2000","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152467_bib0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/09612033707076513","article-title":"Unique hepatic imaging features in a patient with nodular regenerative hyperplasia of the liver associating with systemic lupus erythematosus","volume":"16","author":"Leung","year":"2007","journal-title":"Lupus"},{"issue":"13","key":"10.1016\/j.semarthrit.2024.152467_bib0041","doi-asserted-by":"crossref","first-page":"688","DOI":"10.12998\/wjcc.v6.i13.688","article-title":"Systemic lupus erythematosus complicated by noncirrhotic portal hypertension: a case report and review of literature","volume":"6","author":"Yang","year":"2018","journal-title":"World J Clin Cases"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0042","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00004836-199807000-00021","article-title":"Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies","volume":"27","author":"Perez-Ruiz","year":"1998","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0043","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/ard.2002.001826","article-title":"Hepatic manifestations of autoimmune rheumatic diseases","volume":"63","author":"Abraham","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152467_bib0044","first-page":"901","article-title":"[Nodular regenerative hyperplasia associated with primary antiphospholipid syndrome]","volume":"20","author":"Cadranel","year":"1996","journal-title":"Gastroenterol Clin Biol"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1078\/0171-2985-00209","article-title":"Nodular regenerative hyperplasia (NRH) of the liver\u2013a manifestation of \u201corgan-specific antiphospholipid syndrome\u201d?","volume":"207","author":"Klein","year":"2003","journal-title":"Immunobiology"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152467_bib0046","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0047","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1191\/096120399678847515","article-title":"Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature","volume":"8","author":"Morl\u00e0","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2024.152467_bib0048","doi-asserted-by":"crossref","DOI":"10.1177\/09612033231211820","article-title":"16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome laboratory diagnostics and trends","author":"Atsumi","year":"2023","journal-title":"Lupus"},{"issue":"16","key":"10.1016\/j.semarthrit.2024.152467_bib0049","doi-asserted-by":"crossref","first-page":"9432","DOI":"10.3390\/ijms23169432","article-title":"IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus","volume":"23","author":"Reshetnyak","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3899\/jrheum.170292","article-title":"Nodular regenerative hyperplasia of the liver: a rare vascular complication in systemic sclerosis","volume":"45","author":"Graf","year":"2018","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152467_bib0051","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.semarthrit.2017.10.004","article-title":"Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: characteristics and survival of patients from the Spanish RESCLE Registry","volume":"47","author":"Mar\u00ed-Alfonso","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152467_bib0052","article-title":"Non-cirrhotic portal hypertension as the initial presentation of limited cutaneous scleroderma: a case report","volume":"11","author":"Hitawala","year":"2023","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152467_bib0053","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/MEG.0b013e32833ab83a","article-title":"Gastric variceal bleeding uncovering a rare association of CREST syndrome, primary biliary cirrhosis, nodular regenerative hyperplasia and pulmonary hypertension","volume":"22","author":"Riviere","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0054","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12969-022-00690-x","article-title":"Nodular Regenerative hyperplasia of the liver in juvenile dermatomyositis","volume":"20","author":"Lanis","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.semarthrit.2024.152467_bib0055","article-title":"Diffuse muscular pain, skin tightening, and nodular regenerative hyperplasia revealing paraneoplastic amyopathic dermatomyositis due to testicular cancer","volume":"2012","author":"Norrenberg","year":"2012","journal-title":"Case Rep Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0056","first-page":"168","article-title":"Nodular regenerative hyperplasia of the liver and primary Sj\u00f6gren's syndrome","volume":"21","author":"Gonz\u00e1lez-Alvaro","year":"1994","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152467_bib0057","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s10067-005-1084-y","article-title":"Idiopathic portal hypertension associated with systemic sclerosis and Sj\u00f6gren's syndrome","volume":"24","author":"Kogawa","year":"2005","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152467_bib0058","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/liv.12936","article-title":"Obliterative portal venopathy without portal hypertension: an underestimated condition","volume":"36","author":"Guido","year":"2016","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152467_bib0059","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/BF02936959","article-title":"Mixed connective tissue disease associated with idiopathic portal hypertension and chronic thyroiditis","volume":"32","author":"Hirasaki","year":"1997","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.hepres.2004.06.001","article-title":"A case of merged idiopathic portal hypertension in course of mixed connective tissue disease","volume":"30","author":"Rai","year":"2004","journal-title":"Hepatol Res"},{"issue":"18","key":"10.1016\/j.semarthrit.2024.152467_bib0061","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2169\/internalmedicine.49.3834","article-title":"Idiopathic portal hypertension in a patient with mixed connective tissue disease and protein C deficiency","volume":"49","author":"Horai","year":"2010","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152467_bib0062","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/s10165-006-0479-1","article-title":"A case of systemic sclerosis complicated by idiopathic portal hypertension: case report and literature review","volume":"16","author":"Takagi","year":"2006","journal-title":"Mod Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2024.152467_bib0063","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/jcp.27.12.963","article-title":"Nodular, non-cirrhotic liver associated with portal hypertension in a patient with rheumatoid arthritis","volume":"27","author":"Harris","year":"1974","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152467_bib0064","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00004836-200210000-00020","article-title":"Nodular regenerative hyperplasia in a rheumatoid arthritis patient without felty's syndrome","volume":"35","author":"Goritsas","year":"2002","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152467_bib0065","first-page":"838","article-title":"Nodular regenerative hyperplasia of the liver in a patient with rheumatoid vasculitis: a morphometric study suggesting a role for hepatic arteritis in the pathogenesis","volume":"11","author":"Reynolds","year":"1984","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152467_bib0066","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.path.2023.04.005","volume":"16","author":"Fiel","year":"2023","journal-title":"Surg Pathol Clin"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0067","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0002-9343(82)90921-4","article-title":"Liver disease in Felty's syndrome","volume":"73","author":"Thorne","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2024.152467_bib0068","article-title":"Porto-Sinusoidal Vascular Disease as the Cause of Portal Hypertension in Felty's Syndrome: a Case Report and Literature Review","volume":"2020","author":"Yang","year":"2020","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0069","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0049-0172(91)90056-6","article-title":"Nodular regenerative hyperplasia of the liver in rheumatic diseases: report of seven cases and review of the literature","volume":"21","author":"Perez Ruiz","year":"1991","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0070","first-page":"133","article-title":"Nodular regenerative hyperplasia of the liver associated with polyarteritis nodosa","volume":"108","author":"Nakanuma","year":"1984","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152467_bib0071","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0168-8278(97)80441-2","article-title":"Intrahepatic bile duct injury and nodular regenerative hyperplasia of the liver in a patient with polyarteritis nodosa","volume":"26","author":"Goritsas","year":"1997","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152467_bib0072","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2169\/internalmedicine.51.5638","article-title":"Interstitial pneumonia and nodular regenerative hyperplasia of the liver as initial manifestations of polyarteritis nodosa","volume":"51","author":"Tanaka","year":"2012","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0073","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/BOR.0000000000000126","article-title":"Rheumatoid vasculitis: an update","volume":"27","author":"Makol","year":"2015","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0074","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00004836-199203000-00011","article-title":"The pathogenesis of nodular regenerative hyperplasia of the liver associated with rheumatoid vasculitis","volume":"14","author":"Young","year":"1992","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"10.1016\/j.semarthrit.2024.152467_bib0075","doi-asserted-by":"crossref","first-page":"e00812","DOI":"10.14309\/crj.0000000000000812","article-title":"Porto-Sinusoidal Vascular Disease in a Patient With Diffuse Aortitis and Massive Ascites","volume":"9","author":"Lin","year":"2022","journal-title":"ACG Case Rep J"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152467_bib0076","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2559.1992.tb01023.x","article-title":"Nodular regenerative hyperplasia of the liver in Beh\u00e7et's disease","volume":"20","author":"Bloxham","year":"1992","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152467_bib0077","first-page":"e1125","article-title":"A Rare cause of portal hypertension: behcet's disease and nodular regenerative hyperplasia of the liver","volume":"9","author":"Philips","year":"2017","journal-title":"Cureus."},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0078","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41584-022-00880-7","article-title":"Vascular Beh\u00e7et syndrome: from pathogenesis to treatment","volume":"19","author":"Bettiol","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0079","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41572-021-00301-1","article-title":"Beh\u00e7et syndrome","volume":"7","author":"Yazici","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10067-021-05878-2","article-title":"Budd-Chiari syndrome in Beh\u00e7et's disease: a retrospective multicenter study","volume":"41","author":"Akyol","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"20","key":"10.1016\/j.semarthrit.2024.152467_bib0081","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1056\/NEJMoa1014460","article-title":"Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis","volume":"365","author":"Dooley","year":"2011","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.semarthrit.2024.152467_bib0082","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199510123331502","article-title":"Azathioprine for long-term maintenance of remission in autoimmune hepatitis","volume":"333","author":"Johnson","year":"1995","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.semarthrit.2024.152467_bib0083","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152467_bib0084","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Beh\u00e7et's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0086","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.crohns.2010.08.007","article-title":"Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease","volume":"5","author":"Calabrese","year":"2011","journal-title":"J Crohns Colitis"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152467_bib0087","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1136\/gut.2006.114363","article-title":"Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine","volume":"56","author":"Vernier-Massouille","year":"2007","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0088","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ibd.21330","article-title":"Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine","volume":"17","author":"Seksik","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152467_bib0089","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/apt.12490","article-title":"Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy","volume":"38","author":"Musumba","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152467_bib0090","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.cgh.2018.05.009","article-title":"Clinical course of nodular regenerative hyperplasia in thiopurine treated inflammatory bowel disease patients","volume":"17","author":"Simsek","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2024.152467_bib0091","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/j.1572-0241.2007.01530.x","article-title":"6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension","volume":"102","author":"Ferlitsch","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.semarthrit.2024.152467_bib0092","article-title":"Treatable Traits in Systemic Sclerosis","author":"Amati","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0093","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0000000000000125","article-title":"An update on the diagnosis, treatment, and prognosis of intestinal Beh\u00e7et's disease","volume":"27","author":"Cheon","year":"2015","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0094","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.md.0000158825.87055.0b","volume":"84","author":"Pagnoux","year":"2005","journal-title":"Med (Baltimore)"},{"issue":"11\u201312","key":"10.1016\/j.semarthrit.2024.152467_bib0095","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/apt.17727","article-title":"Association between gut-derived endotoxins and porto-sinusoidal vascular disorder with portal hypertension","volume":"58","author":"Gioia","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152467_bib0096","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/0002-9343(81)90828-7","article-title":"Nodular regenerative hyperplasia of the liver associated with macroglobulinemia. A clue to the pathogenesis","volume":"70","author":"Wanless","year":"1981","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152467_bib0097","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/09612033211066459","article-title":"Lupus band test for diagnostic evaluation in systemic lupus erythematosus","volume":"31","author":"Wongtada","year":"2022","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152467_bib0098","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on Lupus Nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0099","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/BF03041263","article-title":"A case of idiopathic portal hypertension associated with systemic lupus erythematosus","volume":"9","author":"Nakajima","year":"1999","journal-title":"Japanese Journal of Rheumatology"},{"key":"10.1016\/j.semarthrit.2024.152467_bib0100","article-title":"Spectrum of Histomorphologic Findings in Liver in Patients with SLE: a Review","volume":"2014","author":"Grover","year":"2014","journal-title":"Hepat Res Treat"},{"issue":"7","key":"10.1016\/j.semarthrit.2024.152467_bib0101","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1440-1746.2006.04822.x","article-title":"Experimental investigation of the role of endothelin-1 in idiopathic portal hypertension","volume":"22","author":"Yamaguchi","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152467_bib0102","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1872-034X.2009.00555.x","article-title":"Pathology and pathogenesis of portal venopathy in idiopathic portal hypertension: hints from systemic sclerosis","volume":"39","author":"Nakanuma","year":"2009","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0103","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/RHU.0000000000001229","article-title":"Posterior Reversible Encephalopathy Syndrome and Idiopathic Noncirrhotic Portal Hypertension in a Patient With Systemic Sclerosis","volume":"27","author":"Gao","year":"2021","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0104","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/ard.2008.102400","article-title":"Anti-endothelial cell antibodies in systemic sclerosis","volume":"69","author":"Mihai","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152467_bib0105","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1111\/liv.14997","article-title":"Autoimmune biomarkers in porto-sinusoidal vascular disease: potential role in its diagnosis and pathophysiology","volume":"41","author":"Cerda Reyes","year":"2021","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0106","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0394632015572750","article-title":"From microvasculature to fibroblasts: contribution of anti-endothelial cell antibodies in systemic sclerosis","volume":"28","author":"Corallo","year":"2015","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0107","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/cdd.2009.124","article-title":"Caspase-3-mediated secretion of connective tissue growth factor by apoptotic endothelial cells promotes fibrosis","volume":"17","author":"Laplante","year":"2010","journal-title":"Cell Death Differ"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0108","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1440-1746.2002.02587.x","article-title":"Overlap of idiopathic portal hypertension and scleroderma: report of two autopsy cases and a review of literature","volume":"17","author":"Tsuneyama","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0109","first-page":"145","article-title":"Role of endothelial-mesenchymal transition in idiopathic portal hypertension","volume":"28","author":"Sato","year":"2013","journal-title":"Histol Histopathol"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0110","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2353\/ajpath.2009.081061","article-title":"Endothelial to mesenchymal transition via transforming growth factor-beta1\/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension","volume":"175","author":"Kitao","year":"2009","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152467_bib0111","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ajpath.2011.06.001","article-title":"Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders","volume":"179","author":"Piera-Velazquez","year":"2011","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.semarthrit.2024.152467_bib0112","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/art.30317","article-title":"Protein kinase C\u03b4 and c-Abl kinase are required for transforming growth factor \u03b2 induction of endothelial-mesenchymal transition in vitro","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152467_bib0113","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S2213-2600(20)30364-7","article-title":"Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study","volume":"9","author":"Duckworth","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152467_bib0114","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2018.05.006","article-title":"Hepatic manifestations of telomere biology disorders","volume":"69","author":"Patnaik","year":"2018","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152467_bib0115","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/thx.2008.099796","article-title":"Familial idiopathic pulmonary fibrosis in association with bone marrow hypoplasia and hepatic nodular regenerative hyperplasia: a new \u201ctrimorphic\u201d syndrome","volume":"64","author":"Talbot-Smith","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.semarthrit.2024.152467_bib0116","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/asheducation-2010.1.30","article-title":"Telomere biology and telomere diseases: implications for practice and research","volume":"2010","author":"Young","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152467_bib0117","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1378\/chest.15-0825","article-title":"Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders","volume":"148","author":"Gorgy","year":"2015","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152467_bib0118","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/thorax-2021-218139","article-title":"MUC5B, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung Study","volume":"78","author":"Kim","year":"2023","journal-title":"Thorax"},{"issue":"23","key":"10.1016\/j.semarthrit.2024.152467_bib0119","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.semarthrit.2024.152467_bib0120","doi-asserted-by":"crossref","first-page":"15589","DOI":"10.3390\/ijms242115589","article-title":"Contribution of Telomere Length to Systemic Sclerosis Onset: a Mendelian Randomization Study","volume":"24","author":"Rodriguez-Martin","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.semarthrit.2024.152467_bib0121","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/annrheumdis-2021-221425","article-title":"Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials","volume":"81","author":"Vital","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152467_bib0122","article-title":"Endothelial response to type I interferon contributes to vasculopathy and fibrosis and predicts disease progression of systemic sclerosis","author":"Yin","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152467_bib0123","doi-asserted-by":"crossref","unstructured":"Tonutti A., Motta F., Ceribelli A., Isailovic N., Selmi C., De Santis M. Anti-MDA5 antibody linking COVID-19, type I interferon, and autoimmunity: a case report and systematic literature review. Front Immunol [Internet]. 1AD [cited 2022 Jun 24];0. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.937667\/abstract.","DOI":"10.3389\/fimmu.2022.937667"},{"issue":"8","key":"10.1016\/j.semarthrit.2024.152467_bib0124","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type I interferonopathies: 10 years on","volume":"22","author":"Crow","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152467_bib0125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/annrheumdis-2021-221814","article-title":"The 2021 European Alliance of Associations for Rheumatology\/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE\/PRAAS, SAVI and AGS","volume":"81","author":"Cetin Gedik","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152467_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108837","article-title":"Type I interferon activation in RAS-associated autoimmune leukoproliferative disease (RALD)","volume":"231","author":"Papa","year":"2021","journal-title":"Clin Immunol"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152467_bib0127","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/art.22860","article-title":"A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/anti-Ro 60 autoantibodies","volume":"56","author":"Eloranta","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152467_bib0128","article-title":"Combined anti-Ro52\/TRIM21 and anti-Ro60\/SSA antibodies are associated with increased Sj\u00f6gren's disease severity through interferon pathway activation","author":"Bettacchioli","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0129","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002795","article-title":"Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis","volume":"9","author":"Ida","year":"2023","journal-title":"RMD Open"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152467_bib0130","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/art.22033","article-title":"Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate","volume":"54","author":"Maini","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"10038","key":"10.1016\/j.semarthrit.2024.152467_bib0131","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","article-title":"Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial","volume":"387","author":"Khanna","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152467_bib0132","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"19","key":"10.1016\/j.semarthrit.2024.152467_bib0133","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1093\/emboj\/17.19.5588","article-title":"Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver","volume":"17","author":"Maione","year":"1998","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0134","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s10620-005-1601-5","article-title":"Nodular regenerative hyperplasia of the liver and Castleman's disease: potential role of interleukin-6","volume":"50","author":"Kiyuna","year":"2005","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0135","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ajpath.2013.04.027","article-title":"An ENU mutagenesis-derived mouse model with a dominant Jak1 mutation resembling phenotypes of systemic autoimmune disease","volume":"183","author":"Sabrautzki","year":"2013","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152467_bib0136","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s00330-022-09132-4","article-title":"Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder","volume":"33","author":"Lampichler","year":"2023","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0137","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/hep.31688","article-title":"Liver stiffness by transient elastography to detect porto-sinusoidal vascular liver disease with portal hypertension","volume":"74","author":"Elkrief","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0138","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.dld.2022.09.018","article-title":"Splenic-hepatic elastography index is useful in differentiating between porto-sinusoidal vascular disease and cirrhosis in patients with portal hypertension","volume":"55","author":"Ferreira-Silva","year":"2023","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152467_bib0139","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.hbpd.2023.07.001","article-title":"Application of ultrasonography-elastography score to suspect porto-sinusoidal vascular disease in patients with portal vein thrombosis","volume":"23","author":"Gioia","year":"2024","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"11","key":"10.1016\/j.semarthrit.2024.152467_bib0140","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1111\/liv.15709","article-title":"Diagnostic performance of transient elastography in differentiation between porto-sinusoidal vascular liver disease and compensated cirrhosis","volume":"43","author":"Zhang","year":"2023","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152467_bib0141","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1513\/AnnalsATS.201808-565CME","article-title":"Interstitial Pneumonia with Autoimmune Features","volume":"16","author":"Graney","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"162","key":"10.1016\/j.semarthrit.2024.152467_bib0142","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0177-2021","article-title":"Interstitial pneumonia with autoimmune features: challenges and controversies","volume":"30","author":"Mackintosh","year":"2021","journal-title":"Eur Respir Rev"},{"issue":"7","key":"10.1016\/j.semarthrit.2024.152467_bib0143","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/annrheumdis-2018-214436","article-title":"Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective","volume":"78","author":"Damoiseaux","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152467_bib0144","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.dld.2012.05.005","article-title":"Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension","volume":"44","author":"Seijo","year":"2012","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152467_bib0145","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jceh.2017.03.002","article-title":"Transient Elastography (Fibroscan) in Patients with Non-cirrhotic Portal Fibrosis","volume":"7","author":"Sharma","year":"2017","journal-title":"J Clin Exp Hepatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T02:47:59Z","timestamp":1720061279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017224001070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":145,"alternative-id":["S0049017224001070"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152467","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The autoimmune landscape of Porto-sinusoidal vascular disorder: What the rheumatologist needs to know","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152467"}}